Ann: BIOTRON CLINICAL TRIAL RESULTS WEBINAR, page-51

I fully expect a 'yes' to that question. They have been saying for over a decade that they are in talks with BPs. Hard to prove or disprove at this stage. The only proof will be deal.

The issue with Biotron is that the execs have talked up a good game for too long now. It is like the 'boy who cried wolf' story. I put 'Biotron' into google yesterday and the first thing that popped up for me was an AFR article from 2014 saying they are going to cure Hep C. Can only keep telling holders and the broader market that they will get a deal and a cure / treatment for Ebola, HIV, Hep C, Hep B, SARS, Cancer...It has got to the stage where hardly anyone believes the narrative.

Today is an attempt to increase the share price and stop the slow bleed. Tell everyone how well they are doing. CR fluff. Hopefully everyone else is cynical enough to the understand what this is.